The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry

被引:15
|
作者
Lee, Kyung-Jong [1 ]
Shang, Zeng-Fu [1 ,2 ]
Lin, Yu-Fen [1 ]
Sun, Jingxin [1 ]
Morotomi-Yano, Keiko [1 ]
Saha, Debabrata [1 ]
Chen, Benjamin P. C. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA
[2] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Sch Radiol & Interdisciplinary Sci,Dept Radiobiol, Suzhou, Jiangsu, Peoples R China
来源
NEOPLASIA | 2015年 / 17卷 / 04期
基金
美国国家卫生研究院;
关键词
DOUBLE-STRAND BREAK; HUMAN SOMATIC-CELLS; CYCLIN B1; MICROTUBULE NUCLEATION; CHROMOSOMAL STABILITY; CANCER-THERAPY; M-PHASE; PHOSPHORYLATION; PLK1; MITOSIS;
D O I
10.1016/j.neo.2015.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the key regulator of the non-homologous end joining pathway of DNA double-strand break repair. We have previously reported that DNA-PKcs is required for maintaining chromosomal stability and mitosis progression. Our further investigations reveal that deficiency in DNA-PKcs activity caused a delay in mitotic entry due to dysregulation of cyclin-dependent kinase 1 (Cdk1), the key driving force for cell cycle progression through G2/M transition. Timely activation of Cdk1 requires polo-like kinase 1 (Plk1), which affects modulators of Cdk1. We found that DNA-PKcs physically interacts with Plk1 and could facilitate Plk1 activation both in vitro and in vivo. Further, DNA-PKcs-deficient cells are highly sensitive to Plk1 inhibitor BI2536, suggesting that the coordination between DNA-PKcs and Plk1 is not only crucial to ensure normal cell cycle progression through G2/M phases but also required for cellular resistance to mitotic stress. On the basis of the current study, it is predictable that combined inhibition of DNA-PKcs and Plk1 can be employed in cancer therapy strategy for synthetic lethality.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 50 条
  • [31] Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
    Song, Bing
    Liu, X. Shawn
    Liu, Xiaoqi
    CELL DIVISION, 2012, 7
  • [32] Switching Polo-like kinase-1 on and off in time and space
    Bruinsma, Wytse
    Raaijmakers, Jonne A.
    Medema, Rene H.
    TRENDS IN BIOCHEMICAL SCIENCES, 2012, 37 (12) : 534 - 542
  • [33] Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value
    Evert, M.
    Frau, M.
    Tomasi, M. L.
    Latte, G.
    Simile, M. M.
    Seddaiu, M. A.
    Zimmermann, A.
    Ladu, S.
    Staniscia, T.
    Brozzetti, S.
    Solinas, G.
    Dombrowski, F.
    Feo, F.
    Pascale, R. M.
    Calvisi, D. F.
    BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2654 - 2664
  • [34] More than just strand breaks: the recognition of structural DNA discontinuities by DNA-dependent protein kinase catalytic subunit
    Dip, R
    Naegeli, H
    FASEB JOURNAL, 2005, 19 (07) : 704 - 715
  • [35] SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function
    Wen, Donghua
    Wu, Jianguo
    Wang, Lei
    Fu, Zheng
    CELL REPORTS, 2017, 21 (08): : 2147 - 2159
  • [36] Identification of Rictor as a Novel Substrate of Polo-like kinase 1
    Shao, Tian
    Liu, Xiaoqi
    CELL CYCLE, 2015, 14 (05) : 755 - 760
  • [37] Putting a bit into the polo-box domain of polo-like kinase 1
    Park J.-E.
    Kim T.-S.
    Meng L.
    Bang J.K.
    Kim B.Y.
    Lee K.S.
    Journal of Analytical Science and Technology, 6 (1)
  • [38] Role of Polo-like kinase 1 in the regulation of the action of p31comet in the disassembly of mitotic checkpoint complexes
    Kaisari, Sharon
    Shomer, Pnina
    Ziv, Tamar
    Sitry-Shevah, Danielle
    Teichner, Adar
    Miniowitz-Shemtov, Shirly
    Hershko, Avram
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (24) : 11725 - 11730
  • [39] Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma
    Cheng, Li
    Wang, Chongchong
    Jing, Juehua
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (10) : 1347 - 1350
  • [40] Regulation of polo-like kinase 1 by DNA damage and PP2A/B55α
    Wang, Ling
    Guo, Qingyuan
    Fisher, Laura A.
    Liu, Dongxu
    Peng, Aimin
    CELL CYCLE, 2015, 14 (01) : 157 - 166